title: Duramed Pharmaceuticals targets women's health.
mesh_terms: D000569:Americas; D001695:Biology; D003257:Consumer Product Safety; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D017135:Desogestrel; D019049:Developed Countries; D004703:Endocrine System; D004967:Estrogens; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D006077:Government Agencies; D006728:Hormones; D007878:Legislation as Topic; D009656:North America; D009938:Organizations; D010827:Physiology; D014481:United States; D014486:United States Food and Drug Administration; D014492:United States Public Health Service
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D006728:Hormones; D004997:Ethinyl Estradiol; D017135:Desogestrel
keywords: Americas; Biology; Contraception; Contraception Research; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Desogestrel; Developed Countries; Endocrine System; Estrogens; Ethinyl Estradiol; Family Planning; Government Agencies; Hormones; Legislation; North America; Northern America; Oral Contraceptives; Organizations; Physiology; Product Approval; United States; Usfda; Usphs